Innoviva, Inc. - Director, 10%+ Owner at Armata Pharmaceuticals, Inc.

Issuer-level insider activity

Role
Director, 10%+ Owner
Issuer ticker
ARMP on NYSE
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Innoviva, Inc. since 03 Aug 2025

Reported holdings for Innoviva, Inc. in Armata Pharmaceuticals, Inc.

Form 4 holding Director, 10%+ Owner

Armata Pharmaceuticals, Inc.

Security class
Convertible Debt convertible into Common Stock
Shares / value
$30,000,000
Estimated value
Report date
10 Jan 2023
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Transaction history for Innoviva, Inc. in Armata Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .